Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun;15(2):165-166.
doi: 10.1007/s11481-020-09919-6. Epub 2020 May 7.

Feasibility of Therapeutic Effects of the Cholinergic Anti-Inflammatory Pathway on COVID-19 Symptoms

Affiliations
Comment

Feasibility of Therapeutic Effects of the Cholinergic Anti-Inflammatory Pathway on COVID-19 Symptoms

Roham Mazloom. J Neuroimmune Pharmacol. 2020 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declare that there is no conflict of interest.

Comment on

  • COVID-19: consider cytokine storm syndromes and immunosuppression.
    Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. Mehta P, et al. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16. Lancet. 2020. PMID: 32192578 Free PMC article. No abstract available.

References

    1. Chu C, Artis D, Chiu IM. Neuro-immune interactions in the tissues. Immunity. 2020;52:464–474. doi: 10.1016/j.immuni.2020.02.017. - DOI - PMC - PubMed
    1. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London, England) 2020;6736:19–20. doi: 10.1016/S0140-6736(20)30628-0. - DOI - PMC - PubMed
    1. Reardon C. Neuro-immune interactions in the cholinergic anti-inflammatory reflex. Immunol Lett. 2016;178:92–96. doi: 10.1016/j.imlet.2016.08.006. - DOI - PubMed
    1. Venkiteshwaran A. Tocilizumab. MAbs. 2013;1:432–438. doi: 10.4161/mabs.1.5.9497. - DOI - PMC - PubMed
    1. Yamada M, Ichinose M. The cholinergic anti-inflammatory pathway: an innovative treatment strategy for respiratory diseases and their comorbidities. Curr Opin Pharmacol. 2018;40:18–25. doi: 10.1016/j.coph.2017.12.003. - DOI - PubMed

LinkOut - more resources